Zheng et al. (2012) found that TMP exhibited the same dose- and time-dependent inhibitory effect on the proliferation of the lung cancer cell line A549 by suppressing cell cycle progression, which resulted in the inhibition of invasion in vitro and suppression of metastatic growth in an in vivo metastatic nude mouse model by targeting COX-2. Here, MTCO2P12 is linked to lung carcinoma.